Bioequivalence Study to Compare Chenodeoxycholic Acid Capsules (250mg Chenodeoxycholic Acid) Versus Chenodeoxycholic Acid Leadiant 250 mg Hard Capsules (250mg Chenodeoxycholic Acid)
Clinical trial NCT06180057 · COMPLETED
Trial details
- NCT number
- NCT06180057
- Sponsor
- Humanis Saglık Anonim Sirketi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-12
- Primary completion
- 2022-07-18
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.